Glioblastoma multiforme (GBM) is a highly aggressive, complex, and devastating form of brain cancer, effecting hundreds of people each day. We believe it is our duty to accelerate progress against this disease so we launched the Defeat GBM Research Collaborative in 2013 with the intent to double the 5 year survival rate of GBM patients. This comes at a time when collaboration is becoming the norm and the abundance of genomic data is accelerating diagnostic, prognostic, and therapeutic progress.
Oligo Research Fund
Oligodendroglioma (oligo) is a relatively rare brain tumor representing about 6% of gliomas, with a diagnosis rate of about 1,150 patients a year in the U.S. alone. Critical research is required to deliver oligo patients new therapies that are more durable and extend their lives. In order to make effective, targeted therapies a reality it is essential to identify and understand the molecular drivers of the tumor’s genesis and maintenance, as well as resistance.
Our new pediatric initiative, Project Impact, will leverage increases in knowledge gained from earlier funded research efforts, and develop a program that can address critical barriers to progress within the drug discovery and development pipeline through an integrated approach to advance research toward new treatments for pediatric brain tumor patients.
The Community Research Fund allows contributors to pool donations to support research on a specific type of tumor. This program leverages a team of highly experienced, nationally-recognized scientific experts, working with National Brain Tumor Society staff, to determine the best investment strategy for each fund.
From the Blog
October 22, 2014
Hope for GBM Patients
Recent news and conversations across social media has churned up a lot of concern and fear over glioblastoma multiforme (GBM) tumors. And while we know all too well it’s the deadliest form of brain cancer with dismal survival rates, we also want the public to know how the National Brain Tumor Society is working to […]Read more |
October 10, 2014
Advocating for Childhood Cancer Cures
National Brain Tumor Society is driven to create change for the more than 4,000 children and their families who will receive the terrible diagnosis of a pediatric brain tumor this year. In addition to our funded initiatives, we also are committed to working with the greater pediatric cancer community to help advance research toward new […]Read more |
October 9, 2014
National Brain Tumor Society 2014 Summit Reviews Systemic Change Happening in Brain Cancer Research & Development, Honors Community Leaders
National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, hosted its 2014 Summit and Annual Meeting in Cambridge, MA, on October 1-2. The yearly event brought together a cross-section of the brain tumor community, including neuro-oncologists, medical academics, biotechnology and pharmaceutical executives, representatives from the National Institutes […]Read more |